MRI-Based Radiomic Signature Identifying Secondary Loss of Response to Infliximab in Crohn's Disease

Up to 50% of patients with Crohn's disease (CD) experience secondary loss of response (SLR) to infliximab. Patients with SLR may show clinical signs of iron deficiency as a result of inflammation despite being iron-replete. The magnetic resonance imaging (MRI)-based radiomic index, R2(*), can d...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jing, Feng, Qi, Chen, Yueying, Yang, Tian, Cheng, Saiming, Qiao, Yuqi, Shen, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763017/
https://www.ncbi.nlm.nih.gov/pubmed/35047543
http://dx.doi.org/10.3389/fnut.2021.773040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763017/
https://www.ncbi.nlm.nih.gov/pubmed/35047543
http://dx.doi.org/10.3389/fnut.2021.773040

Ejemplares similares